Caroline Thomas

Caroline Thomas is a seasoned financial professional with a robust background in financial analysis and compliance. Currently serving as a Senior Financial Analyst at Prime Therapeutics since December 2022, following the company's acquisition of Magellan Rx Management, Caroline previously held similar roles at Magellan Rx Management and the Florida Office of Financial Regulation. Caroline's experience includes conducting compliance examinations, analyzing financial performance in health care, and managing procurement processes, demonstrating expertise in financial oversight across various sectors. With a Bachelor of Arts in Business Administration and Accounting from Flagler College-Tallahassee, Caroline combines educational knowledge with practical experience to drive financial performance and ensure compliance.